Gemcabene for the Treatment of Pediatric NAFLD: A Phase 2a Study

Trial Profile

Gemcabene for the Treatment of Pediatric NAFLD: A Phase 2a Study

Recruiting
Phase of Trial: Phase II

Latest Information Update: 13 Apr 2018

At a glance

  • Drugs Gemcabene (Primary)
  • Indications Non-alcoholic fatty liver disease
  • Focus Pharmacodynamics; Proof of concept
  • Most Recent Events

    • 09 Apr 2018 Status changed from not yet recruiting to recruiting.
    • 06 Mar 2018 Planned initiation date changed from 1 Feb 2018 to 1 Mar 2018.
    • 11 Feb 2018 Status changed from recruiting to not yet recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top